Drug:
Reaction: PYREXIA
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26928347 |
US |
50 | 1 |
Pyrexia, |
||||
TALQUETAMAB, |
||||
| 202 | 26928374 |
EU |
||
Encephalitis, Impaired healing, Gastrointestinal disorder, Fatigue, Decreased appetite, Weight decreased, Pyrexia, Rash, Pruritus, Psoriasis, Toxic epidermal necrolysis, Colitis, Diarrhoea, Alanine aminotransferase increased, Hepatic function abnormal, Hypothyroidism, Adrenal insufficiency, Arthritis, Myalgia, Polyneuropathy, Pneumonitis, Myocarditis, Cardiac failure, Oesophageal varices haemorrhage, Upper gastrointestinal haemorrhage, Hypertension, Proteinuria, Embolism, Hepatitis, Portal hypertension, Peptic ulcer haemorrhage, Myocardial ischaemia, Gastric ulcer perforation, Hepatic failure, Tracheo-oesophageal fistula, |
||||
ATEZOLIZUMAB, BEVACIZUMAB, |
||||
| 203 | 26928416 |
DO |
35 | 2 |
Viral infection, Headache, Pyrexia, Abdominal discomfort, Diarrhoea, Pharyngitis, Dehydration, |
||||
DUPILUMAB, |
||||
| 204 | 26928543 |
EG |
42 | 2 |
Cholecystectomy, Condition aggravated, Mobility decreased, Urinary incontinence, Constipation, Visual acuity reduced, Pyrexia, Dizziness, Headache, |
||||
FINGOLIMOD HCL, FINGOLIMOD, FINGOLIMOD HYDROCHLORIDE, |
||||
| 205 | 26928546 |
CA |
44 | 2 |
Lower respiratory tract infection, Infection, Swelling, Peripheral swelling, Joint swelling, Stomatitis, Sleep disorder due to general medical condition, insomnia type, Weight increased, Nasopharyngitis, Muscle injury, Pyrexia, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, RITUXIMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC, DICLOFENAC SODIUM, OXYCODONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 206 | 26928602 |
EU |
2 | |
Dyspnoea, Pyrexia, Chills, Pharyngitis, Asphyxia, |
||||
LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, ALBUTEROL SULFATE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 207 | 26929012 |
EU |
34 | 2 |
Mouth ulceration, Periorbital oedema, Oropharyngeal pain, Pyrexia, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, FOLLITROPIN ALFA, |
||||
| 208 | 26929144 |
CA |
61 | 2 |
Angina pectoris, Appetite disorder, Asthma, Chest discomfort, Chest pain, Cough, Depressed mood, Depressive symptom, Dyspnoea, Dyspnoea exertional, Fall, Flank pain, Heart sounds, Influenza, Injury, Insomnia, Loss of personal independence in daily activities, Lower respiratory tract infection, Malaise, Nasal congestion, Nasopharyngitis, Productive cough, Prolonged expiration, Pyrexia, Rales, Respiration abnormal, Rhinorrhoea, Sleep disorder due to a general medical condition, Stress, Upper respiratory tract infection, Weight decreased, Wheezing, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, DIMENHYDRINATE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FUROSEMIDE, NITROGLYCERIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MOMETASONE, MOMETASONE, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), NITROGLYCERIN, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, QUINAPRIL, QUINAPRIL HYDROCHLORIDE, ALBUTEROL SULFATE, ALBUTEROL, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, |
||||
| 209 | 26929149 |
CO |
55 | 2 |
Vomiting, Dyspnoea, Migraine, Pyrexia, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 210 | 26929212 |
CL |
57 | 2 |
Dyspnoea, Nasopharyngitis, Immunodeficiency, Arthralgia, Suffocation feeling, Pyrexia, Pain in extremity, Peripheral swelling, Inflammation, Hand deformity, |
||||
UPADACITINIB, PREDNISONE, PREGABALIN, CELECOXIB, |
||||
| 211 | 26929386 |
JP |
6 | 1 |
Colitis ulcerative, Pyrexia, Nasopharyngitis, Blood lactate dehydrogenase increased, |
||||
PEGCETACOPLAN, PEGCETACOPLAN, |
||||
| 212 | 26929906 |
US |
2 | 1 |
Pyrexia, |
||||
DUPILUMAB, |
||||
| 213 | 26930059 |
US |
2 | |
Sputum discoloured, Sputum abnormal, Pyrexia, Chills, Cough, Malaise, |
||||
BRENSOCATIB, |
||||
| 214 | 26930222 |
CA |
44 | 2 |
Lower respiratory tract infection, Autoimmune disorder, Live birth, Pericarditis, Contraindicated product administered, Peripheral swelling, Pyrexia, Underdose, Synovitis, Drug intolerance, Maternal exposure timing unspecified, Exposure during pregnancy, Therapeutic product effect decreased, Pregnancy, Ill-defined disorder, Treatment failure, Therapy non-responder, Stomatitis, Irritable bowel syndrome, Systemic lupus erythematosus, Gastrointestinal disorder, Helicobacter infection, Product use issue, Pruritus, Glossodynia, Infusion related reaction, Maternal exposure during pregnancy, Weight increased, Prescribed overdose, Wound, Sinusitis, Hypersensitivity, Rheumatoid arthritis, |
||||
LORAZEPAM, LANSOPRAZOLE, LANSOPRAZOLE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ALBUTEROL SULFATE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, MESALAMINE, MESALAMINE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, USTEKINUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, FLUOROMETHOLONE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CAFFEINE, CAFFEINE, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, MOXIFLOXACIN HYDROCHLORIDE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, AZATHIOPRINE, SARILUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, PREGABALIN, PREGABALIN, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, HYDROXYCHLOROQUINE SULFATE, LORAZEPAM, LEFLUNOMIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, OXYCODONE, OXYCODONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, ERYTHROMYCIN, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, MELOXICAM, VITAMIN C, VITAMIN C, VITAMIN C, VITAMIN C, VITAMIN C, VITAMIN C, LANSOPRAZOLE, LANSOPRAZOLE, LISINOPRIL, LISINOPRIL, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, QUETIAPINE FUMARATE, QUETIAPINE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, QUETIAPINE FUMARATE, QUETIAPINE, SULFASALAZINE, ERGOCALCIFEROL, |
||||
| 215 | 26930332 |
US |
||
Feeling abnormal, Bone pain, Pyrexia, Fatigue, |
||||
RUXOLITINIB, |
||||
| 216 | 26930374 |
EU |
40 | 1 |
Acute myelomonocytic leukaemia, Leukopenia, Neutropenia, Pancytopenia, Pyrexia, Skin lesion, Epistaxis, Off label use, |
||||
FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CYCLOSPORINE, |
||||
| 217 | 26930399 |
US |
29 | 1 |
Pyrexia, Eczema, |
||||
DUPILUMAB, TRALOKINUMAB-LDRM, ABROCITINIB, |
||||
| 218 | 26930459 |
BR |
54 | 1 |
Rash maculo-papular, Pyrexia, |
||||
RITUXIMAB-PVVR, ACALABRUTINIB, ATENOLOL, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ACYCLOVIR, |
||||
| 219 | 26930582 |
EU |
45 | 2 |
Oesophageal ulcer, Pyrexia, Colitis ulcerative, Intestinal ulcer, Drug ineffective, Therapeutic response changed, Aphthous ulcer, C-reactive protein increased, White blood cell count increased, Pericardial effusion, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 220 | 26930928 |
MX |
1 | |
Gastrointestinal stromal tumour, Fistula, Pain, Pyrexia, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, |
||||
| 221 | 26930987 |
EU |
59 | 1 |
Dyspnoea, Cough, Pyrexia, Asthenia, Decreased appetite, |
||||
IPRATROPIUM BROMIDE, AMOXICILLIN, |
||||
| 222 | 26931021 |
46 | 2 | |
Arthralgia, Pyrexia, Tenderness, Hypertransaminasaemia, Hyperbilirubinaemia, Headache, Hypopnoea, |
||||
FRUQUINTINIB, TRIFLURIDINE AND TIPIRACIL, |
||||
| 223 | 26921418 |
EU |
21 | 1 |
Coagulation factor decreased, Liver function test increased, Alanine aminotransferase increased, Sleep disorder, Weight increased, Swelling face, Erythema, Fatigue, Coagulation factor decreased, Epstein-Barr virus test positive, Pyrexia, |
||||
BUDESONIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ETRANACOGENE DEZAPARVOVEC, |
||||
| 224 | 26921460 |
US |
49 | 2 |
Nephrolithiasis, Pyrexia, Pain, Asthenia, Upper respiratory tract infection, Increased appetite, Mineral supplementation, Blood urine present, Arthralgia, Unevaluable event, |
||||
RISANKIZUMAB-RZAA, PREDNISONE, |
||||
| 225 | 26921490 |
EU |
52 | 1 |
Oxygen saturation decreased, Lactic acidosis, Pleural effusion, Dyspnoea, Chills, Asthenia, Hypotension, Hypochromic anaemia, Leukocytosis, Somnolence, Pyrexia, Pneumonia, |
||||
NIVOLUMAB, IPILIMUMAB, INSULIN ASPART INJECTION, INSULIN ASPART, INSULIN GLARGINE, |
||||
| 226 | 26921514 |
US |
77 | 1 |
Pyrexia, |
||||
DUPILUMAB, |
||||
| 227 | 26921579 |
CN |
51 | 1 |
Blood fibrinogen decreased, Pyrexia, Cough, |
||||
BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, |
||||
| 228 | 26921633 |
JP |
73 | 1 |
Disseminated intravascular coagulation, Coagulation factor increased, Pyrexia, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 229 | 26921635 |
9 | 2 | |
Diffuse large B-cell lymphoma, Malignant neoplasm progression, Pyrexia, |
||||
EPCORITAMAB-BYSP, EPCORITAMAB-BYSP, |
||||
| 230 | 26921739 |
JP |
7 | |
Interstitial lung disease, Pyrexia, Physical deconditioning, |
||||
ROPEGINTERFERON ALFA-2B, ROPEGINTERFERON ALFA-2B, |
||||
| 231 | 26921805 |
CN |
5 | 2 |
Myelosuppression, Pyrexia, White blood cell count decreased, Neutrophil count decreased, Platelet count decreased, Agranulocytosis, |
||||
DACTINOMYCIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, VINCRISTINE SULFATE, BEVACIZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 232 | 26921840 |
EU |
65 | 1 |
Pyrexia, Anaemia, Hyperglycaemia, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 233 | 26921953 |
EU |
16 | 2 |
Pancytopenia, Gastroenteritis, Pyrexia, |
||||
FILGRASTIM, CAPECITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, |
||||
| 234 | 26922075 |
CN |
70 | 1 |
Headache, Skin ulcer, Skin exfoliation, Rash, Pruritus, Pyrexia, Hypotension, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 235 | 26922092 |
BR |
2 | |
Malaise, Urticaria, Feeding disorder, Pruritus, Nausea, Tongue discomfort, Tongue discolouration, Oedema, Skin plaque, Glossodynia, Plicated tongue, Oropharyngeal pain, Pruritus, Tumour marker increased, Dry mouth, Metastasis, Thrombosis, Bone loss, Immunodeficiency, Metastases to bone, Metastases to lung, Metastases to liver, Osteoporosis, Dry skin, Weight decreased, Wound, Tongue disorder, Oral contusion, Skin disorder, Tongue injury, Tongue injury, Pain of skin, Sensitive skin, Skin irritation, Swelling, Glossitis, Feeding disorder, Tongue disorder, Feeding disorder, Tongue injury, Glossodynia, Swelling, Neck pain, Hypersensitivity, Erythema, Memory impairment, Discomfort, Feeling abnormal, Spinal pain, Pain, Decreased activity, Pain of skin, Adverse drug reaction, Hair colour changes, Tongue injury, Eating disorder, Back pain, Alopecia, Rash macular, Decreased appetite, Liver disorder, Mass, Pain in extremity, Tachycardia, Rib fracture, Rib fracture, Oral contusion, Skin disorder, Arthralgia, Spinal pain, Myalgia, COVID-19, Abdominal pain, Asthenia, Influenza, Pyrexia, Cough, Dyspepsia, Gastrooesophageal reflux disease, Weight decreased, Carbohydrate antigen 125 increased, Yellow skin, Sleep disorder, Tongue erythema, Vomiting, Urticaria, Vomiting, Nausea, Fatigue, Nausea, Fatigue, Headache, Application site pain, Treatment failure, Drug ineffective, Product dose omission issue, Product use in unapproved indication, Product dose omission in error, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, DENOSUMAB, FULVESTRANT, |
||||
| 236 | 26922116 |
BR |
2 | |
Suicide attempt, Suicidal ideation, Asthenia, Pain, Feeling abnormal, Headache, Wound, Asphyxia, Neoplasm, Tumour pain, Apathy, Swelling, Renal impairment, Cardiac arrest, Eye disorder, Cardiac arrest, Coronavirus infection, Neoplasm malignant, Cardiomegaly, Pancreatic enlargement, Abnormal organ growth, Metastatic carcinoid tumour, Throat cancer, Metastasis, Metastasis, Disease recurrence, Metastases to bone, Diabetes mellitus, Bone pain, Bone marrow infiltration, Malaise, Cataract, Acromegaly, Lung disorder, Syncope, Pruritus, Pneumonia, Arrhythmia, Bone disorder, Visual impairment, Nervousness, Agitation, Feeding disorder, Mass, Panic reaction, Fear, Stress, Skin hypertrophy, Skin discolouration, Balance disorder, Hepatomegaly, Crying, Mood altered, Endocrine disorder, Deformity, Dyskinesia, Fall, Foot deformity, Dysphonia, Needle issue, Productive cough, Coating in mouth, Coating in mouth, Hormone level abnormal, Pancreatic disorder, Tongue disorder, Cardiac disorder, Gallbladder disorder, Liver disorder, Bacteroides test positive, Head injury, Malaise, Retching, Laziness, Skin discolouration, Malaise, Gait disturbance, Haemangioma of bone, Yellow skin, Cardiac valve disease, Gait disturbance, Decreased immune responsiveness, Sluggishness, General physical condition abnormal, Cyanosis, Neuralgia, Oropharyngeal pain, Dyspnoea, Pyrexia, Platelet count decreased, Vomiting, Muscular weakness, Decreased appetite, Headache, Asthenia, Headache, Insomnia, Influenza like illness, Anxiety, Dyspnoea, Fatigue, Back pain, Injection site pain, Therapeutic product effect delayed, Incorrect dose administered, Product quality issue, Product storage error, Inappropriate schedule of product administration, Product physical issue, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, SERTRALINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 237 | 26922143 |
US |
82 | 2 |
Intestinal tuberculosis, Ileal ulcer, Escherichia infection, Abdominal pain, Large intestine infection, Pyrexia, Diarrhoea, |
||||
METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, |
||||
| 238 | 26922167 |
PK |
2 | |
Immunosuppression, Pyrexia, Asthenia, |
||||
BEVACIZUMAB, ATEZOLIZUMAB, |
||||
| 239 | 26922270 |
US |
55 | 2 |
Pyrexia, Abdominal pain upper, Headache, Nausea, Chills, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, METHYLPREDNISOLONE SODIUM SUCCINATE, |
||||
| 240 | 26922316 |
CN |
42 | 2 |
Myelosuppression, Pyrexia, Asthenia, Arthralgia, |
||||
PERTUZUMAB, PERTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 241 | 26922328 |
CA |
44 | 2 |
Infection, Infusion related reaction, Irritable bowel syndrome, Muscle injury, Nasopharyngitis, Pain, Pemphigus, Pericarditis, Pyrexia, |
||||
MOXIFLOXACIN HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ALENDRONATE SODIUM, ALENDRONATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC, DICLOFENAC SODIUM, SECUKINUMAB, SECUKINUMAB, |
||||
| 242 | 26922334 |
CA |
58 | 2 |
Thrombocytopenia, Upper respiratory tract infection, Rheumatoid arthritis, Pain, Psoriasis, Pyrexia, Rash, Retching, Temperature regulation disorder, Treatment failure, Off label use, Product use issue, Prescribed overdose, Overdose, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, FUROSEMIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VITAMIN C, VITAMIN C, VITAMIN C, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, MORPHINE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM, SENNOSIDES, ALBUTEROL SULFATE, ALBUTEROL SULFATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ETANERCEPT, GABAPENTIN, ADALIMUMAB, PROGESTERONE, PROGESTERONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, TEMAZEPAM, TEMAZEPAM, SENNOSIDES 8.6 MG TABLETS, SENNOSIDES, SENNA LEAF, SENNA, SENNA LEAF, SENNA LEAF, SENNA LEAF, TEMAZEPAM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ALBUTEROL SULFATE, HYDROMORPHONE HYDROCHLORIDE, KETOPROFEN, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, MORPHINE SULFATE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, NORTRIPTYLINE HYDROCHLORIDE, |
||||
| 243 | 26922395 |
US |
55 | 2 |
Pyrexia, Fatigue, Hyperhidrosis, Lethargy, |
||||
DIROXIMEL FUMARATE, ERGOCALCIFEROL, GABAPENTIN, BACLOFEN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PRIMIDONE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 244 | 26922500 |
CA |
73 | 1 |
Cystitis bacterial, Pyrexia, |
||||
UPADACITINIB, |
||||
| 245 | 26922553 |
CO |
9 | 2 |
Dyspnoea, Pyrexia, |
||||
PALIVIZUMAB, |
||||
| 246 | 26922587 |
CH |
24 | 1 |
Neutropenia, Pyrexia, Respiratory syncytial virus infection, Rhinitis, Balanoposthitis, |
||||
VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CARBOPLATIN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DIMENHYDRINATE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, ATOVAQUONE, ATOVAQUONE ORAL SUSPENSION, AMPHOTERICIN B, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, URSODIOL, URSOSIOL, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 247 | 26922593 |
VN |
50 | 2 |
Metastases to liver, Bone pain, Dyspnoea, Gastrointestinal disorder, Gastritis, Enteritis, Pyrexia, Cough, |
||||
ZOLEDRONIC ACID, CERITINIB, CERITINIB, CERITINIB, |
||||
| 248 | 26922655 |
US |
2 | |
Blood pressure decreased, Pyrexia, |
||||
GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, |
||||
| 249 | 26922708 |
CN |
||
Pyrexia, Diarrhoea, Pneumonia, Liver injury, Infusion related reaction, Herpes virus infection, Intraocular pressure increased, |
||||
RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, VINCRISTINE SULFATE, |
||||
| 250 | 26922758 |
US |
1 | |
Viral infection, Cough, Pyrexia, |
||||
DUPILUMAB, |
||||
| 251 | 26923006 |
CA |
43 | 2 |
Arthralgia, Synovitis, Back injury, Dislocation of vertebra, Breast cancer stage II, Wound, Feeling hot, Infusion related reaction, Osteoporosis, Frequent bowel movements, Peripheral venous disease, Taste disorder, Memory impairment, Folliculitis, Muscle spasms, Musculoskeletal pain, Decreased appetite, Joint range of motion decreased, Depression, Dry mouth, Lung disorder, Migraine, Exostosis, Abdominal discomfort, Blepharospasm, Headache, Blister, Peripheral swelling, Asthenia, Irritable bowel syndrome, Lupus vulgaris, Night sweats, Pericarditis, Paraesthesia, Abdominal pain upper, Bursitis, C-reactive protein increased, Breast cancer stage III, Anti-cyclic citrullinated peptide antibody positive, Visual impairment, Exposure during pregnancy, Contraindicated product administered, General physical health deterioration, Blood cholesterol increased, Inflammation, Hypocholesterolaemia, Glossodynia, Product quality issue, Vomiting, Live birth, Psoriatic arthropathy, Maternal exposure during pregnancy, Weight increased, Impaired healing, Retinitis, Rash, Pain, Dizziness, Pyrexia, Diarrhoea, Gastrooesophageal reflux disease, Hepatic enzyme increased, Joint swelling, Red blood cell sedimentation rate increased, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, SULFASALAZINE, APREMILAST, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ERGOCALCIFEROL, TOFACITINIB, TOFACITINIB, MINOCYCLINE HYDROCHLORIDE, OXYCODONE, OXYCODONE, FLUTICASONE PROPIONATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ADALIMUMAB-ADAZ, CELECOXIB, CELECOXIB, PANTOPRAZOLE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RITUXIMAB, RITUXIMAB, ERENUMAB-AOOE, BOTULINUM TOXIN TYPE A, NAPROXEN, NAPROXEN SODIUM, PHENYLEPHRINE HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, SULFASALAZINE, CANDESARTAN, CANDESARTAN, RANITIDINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SECUKINUMAB, SECUKINUMAB, TRAMADOL HYDROCHLORIDE, GOLIMUMAB, GOLIMUMAB, PREDNISONE, ABATACEPT, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, CYCLOBENZAPRINE, HYDROMORPHONE HYDROCHLORIDE, RAMIPRIL, MEPOLIZUMAB, TOFACITINIB, TOFACITINIB CITRATE, BUPRENORPHINE HYDROCHLORIDE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, PYRIDOXINE HYDROCHLORIDE, INFLIXIMAB, MIRABEGRON, INFLIXIMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, BETAMETHASONE DIPROPIONATE, ERGOCALCIFEROL, APREMILAST, APREMILAST, TRETINOIN, MAGNESIUM CHLORIDE, MAGNESIUM CHLORIDE, VITAMIN C, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RISEDRONATE SODIUM, LISINOPRIL, LORAZEPAM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, QUETIAPINE FUMARATE, QUETIAPINE, FISH OIL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ALBUTEROL SULFATE, |
||||
| 252 | 26923181 |
BR |
2 | |
Drug intolerance, Immunodeficiency, Epistaxis, Loss of consciousness, Haemangioma rupture, Liver injury, Spinal cord disorder, Spinal cord injury, Metastases to spine, Metastases to bone, Metastasis, Metastases to bone, Metastases to liver, Immunodeficiency, Face injury, Skin exfoliation, Dry throat, Alopecia, Erythema, Dry skin, Vulvovaginal dryness, Vulvovaginal discomfort, Vulvovaginal burning sensation, Nasal dryness, Skin disorder, Pruritus, Neoplasm, Gait disturbance, Tumour marker increased, Reflux gastritis, Discouragement, Visual impairment, Greater trochanteric pain syndrome, Feeding disorder, Haemangioma, Disease progression, Weight decreased, Illness, Aphthous ulcer, Oral herpes, Swelling of eyelid, Sinusitis, Rhinitis, Rhinitis allergic, Eyelid sensory disorder, Vein disorder, Frostbite, Ocular hyperaemia, Haemorrhoids, Hair texture abnormal, Trichorrhexis, Eyelid ptosis, Rectocele, Gastrointestinal disorder, Hiatus hernia, Nasal pruritus, Dry eye, Head discomfort, PIK3CA-activated mutation, Swelling, Abdominal discomfort, Head injury, Nasal injury, Skin lesion, Wound, Injury, Oestrogen deficiency, Drug ineffective, Panic disorder, Nasal discomfort, Haematoma, Asthenopia, Hypermetropia, Astigmatism, Petechiae, Dyspnoea, Skeletal injury, Phlebitis, Oral pain, Nasal disorder, Eye swelling, Anosmia, Movement disorder, Pain, Vulvovaginal exfoliation, Chills, Paraesthesia, White blood cell count decreased, Neutrophil count decreased, Pyrexia, Fatigue, Constipation, Dry mouth, Application site bruise, Application site pain, Ear disorder, Urinary tract infection, Skin atrophy, Lip dry, Pain, Pain in extremity, Bone pain, Dysstasia, Application site swelling, Arthralgia, Insomnia, Malaise, Product availability issue, |
||||
FULVESTRANT, ANASTROZOLE, ANASTROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, FULVESTRANT, FULVESTRANT, FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, ERGOCALCIFEROL, ACONITUM NAPELLUS, BRYONIA ALBA, EUPATORIUM PERFOLIATUM, FERRUM PHOSPHORICUM, GELSEMIUM SEMPERVIRENS, KALI BICHROMICUM, KALI LODATUM, ZINCUM GLUCONICUM., DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL, ACONITUM NAPELLUS, ALLIUM CEPA, GELSEMIUM SEMP., ZINCUM GLUCONICUM, BAPTISIA TINCTORIA, ECHINACEA ANGUSTIFOLIA, EUPATORIUM PERFOLIATUM, LOMATIUM DISSECTUM, PUERARIA LOBATA, TRIFOLIUM PRATENSE, PHYTOLACCA DECANDRA, ALLIUM CEPA, ARSENICUM IODATUM, BARYTA CARBONICA, BROMIUM, CALCAREA CARBONICA, KALI MURIATICUM, LACHESIS MUTUS, MERCURIUS SOLUBILIS, SILICEA, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL, |
||||
| 253 | 26923255 |
US |
83 | 2 |
Pyrexia, Decreased appetite, Urinary tract infection, |
||||
VIBEGRON, |
||||
| 254 | 26923310 |
25 | 1 | |
Acute kidney injury, Depressed level of consciousness, Pyrexia, Hyperhidrosis, Agitation, Seizure, Toxicity to various agents, Overdose, |
||||
TRANYLCYPROMINE SULFATE, |
||||
| 255 | 26923547 |
EU |
43 | 1 |
Hepatotoxicity, Pyrexia, Stomatitis, Pain in extremity, Asthenia, Dysphonia, Dyspnoea exertional, |
||||
PEMBROLIZUMAB, |
||||
| 256 | 26923635 |
US |
71 | 2 |
Burning sensation, Rash, Pyrexia, |
||||
LENALIDOMIDE, |
||||
| 257 | 26923699 |
MY |
84 | |
Oxygen saturation decreased, Heart rate increased, Hypertension, Pyrexia, Chills, Intentional product use issue, |
||||
RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, |
||||
| 258 | 26923741 |
US |
1 | |
Pyrexia, |
||||
DUPILUMAB, |
||||
| 259 | 26923867 |
IN |
21 | 2 |
Drug-induced liver injury, Pneumonia fungal, Malassezia infection, Phaeohyphomycosis, Haematological infection, Staphylococcal infection, Staphylococcal infection, Salmonellosis, Granulomatous liver disease, Pulmonary embolism, Pyrexia, Hepatic function abnormal, Osteomyelitis fungal, Osteomyelitis chronic, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, |
||||
| 260 | 26923958 |
JP |
1 | |
Pyrexia, Hepatomegaly, Blood pressure increased, Rash, Pruritus, |
||||
PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, |
||||
| 261 | 26924068 |
CN |
63 | 2 |
Agitation, Pain, Pyrexia, Infusion related reaction, |
||||
INFLIXIMAB, |
||||
| 262 | 26924258 |
US |
72 | 2 |
Myalgia, Arthralgia, Dyspnoea, Fatigue, Pyrexia, Urinary tract infection, |
||||
DUPILUMAB, |
||||
| 263 | 26924368 |
CN |
33 | 2 |
Myelosuppression, Pyrexia, Nausea, Oropharyngeal discomfort, Mouth ulceration, Dysphagia, Hyperpyrexia, Suspected off label use, |
||||
METHOTREXATE SODIUM, |
||||
| 264 | 26924442 |
CN |
48 | 2 |
White blood cell count decreased, Asthenia, Pyrexia, |
||||
EPIRUBICIN HYDROCHLORIDE, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 265 | 26924566 |
GB |
68 | 2 |
Pyrexia, Chills, |
||||
MESALAMINE, |
||||
| 266 | 26924674 |
EU |
25 | 2 |
Deafness, Cytopenia, Bone lesion, Hyperhidrosis, Tinnitus, Pyrexia, Nausea, Drug tolerance decreased, |
||||
FILGRASTIM, VISMODEGIB, VISMODEGIB, VISMODEGIB, CISPLATIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 267 | 26924830 |
US |
2 | |
Pyrexia, |
||||
CYTARABINE, |
||||
| 268 | 26924845 |
CA |
71 | 2 |
Pyrexia, Cough, Tachycardia, Blood pressure increased, |
||||
OSIMERTINIB, |
||||
| 269 | 26924901 |
EU |
62 | 1 |
Erysipelas, Pyrexia, |
||||
SECUKINUMAB, |
||||
| 270 | 26924991 |
TR |
39 | 1 |
Hypersensitivity, Palpitations, Pyrexia, Vomiting, Peripheral swelling, Swelling face, Eye swelling, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, |
||||
| 271 | 26925462 |
CO |
31 | 2 |
Infection, Pyrexia, Abdominal pain, Off label use, |
||||
PANITUMUMAB, |
||||
| 272 | 26925541 |
CH |
84 | 1 |
Hypersensitivity, Myocardial infarction, Device related infection, Lung infiltration, Haemodynamic instability, Pyrexia, Haematological infection, Lymphopenia, Multiple organ dysfunction syndrome, |
||||
CLADRIBINE, CLADRIBINE, CLADRIBINE, PEGFILGRASTIM, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, CLARITHROMYCIN, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, CEFEPIME HYDROCHLORIDE, CEFEPIME, ATOVAQUONE, ATOVAQUONE ORAL SUSPENSION, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, MEROPENEM, |
||||
| 273 | 26925568 |
CN |
61 | 1 |
Eosinophilic granulomatosis with polyangiitis, Infection, Condition aggravated, Temperature intolerance, Chills, Cough, Pyrexia, Back pain, Neutrophil percentage abnormal, Chromaturia, Inappropriate schedule of product administration, |
||||
MEPOLIZUMAB, |
||||
| 274 | 26925629 |
CN |
28 | |
Feeling cold, Pain, Pyrexia, Exposure during pregnancy, |
||||
DINOPROSTONE, |
||||
| 275 | 26925722 |
PR |
75 | 1 |
Syncope, Choking, Pyrexia, Nasopharyngitis, Chest pain, Asthenia, Foot deformity, Hand deformity, |
||||
LENALIDOMIDE, SERTRALINE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, MEMANTINE, MEMANTINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 276 | 26925762 |
BR |
2 | |
White blood cell count decreased, Abdominal pain, Viral infection, Diarrhoea, Leukopenia, Metastasis, Head discomfort, Reaction to excipient, Blood pressure abnormal, Anxiety, Nail discomfort, Constipation, Decreased immune responsiveness, Abdominal discomfort, Flatulence, Tension, Laziness, Blood test abnormal, Illness, Patient-device incompatibility, Nervousness, Insomnia, Lymphoedema, Platelet count abnormal, Malaise, Pain, Abdominal distension, Abdominal discomfort, White blood cell count decreased, Gastrointestinal pain, Abdominal pain upper, Alopecia, Platelet count decreased, Abdominal pain, Pain in extremity, Pain, Nausea, Headache, Nausea, Headache, Vomiting, Pyrexia, Fatigue, |
||||
FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, FULVESTRANT, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 277 | 26925904 |
GB |
2 | |
Abdominal pain upper, Vomiting, Pyrexia, Nausea, Oropharyngeal pain, Headache, Dyspnoea, Rash, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, ALBUTEROL SULFATE, ALBUTEROL, LANSOPRAZOLE, MONTELUKAST, PROGESTERONE, |
||||
| 278 | 26926023 |
EU |
39 | 1 |
Postoperative wound infection, Blood pressure decreased, Condition aggravated, Pyrexia, |
||||
TIGECYCLINE, AZTREONAM, |
||||
| 279 | 26926061 |
CA |
22 | 1 |
Device related infection, Migraine, Pyrexia, Nausea, Decreased appetite, |
||||
NUSINERSEN, NUSINERSEN, DESMOPRESSIN ACETATE, |
||||
| 280 | 26926139 |
EU |
50 | 2 |
Chills, Tremor, Pyrexia, Hypotension, Nausea, Pain, |
||||
TRASTUZUMAB, |
||||
| 281 | 26926169 |
EU |
79 | 1 |
Dermatitis exfoliative generalised, Oedema peripheral, Hypocalcaemia, Dyspnoea, Oedema genital, Pyrexia, Blood phosphorus decreased, Eosinophilia, |
||||
DENOSUMAB, RELUGOLIX, APALUTAMIDE, |
||||
| 282 | 26926295 |
EU |
57 | 2 |
Diarrhoea haemorrhagic, Immune-mediated enterocolitis, Hypertransaminasaemia, Weight decreased, Renal failure, Septic shock, Pneumonia, Pseudomonal sepsis, Thrombocytopenia, Gastrointestinal haemorrhage, Hypovolaemic shock, Blood loss anaemia, Eastern Cooperative Oncology Group performance status worsened, Pyrexia, Neck pain, Rectal abscess, |
||||
NIVOLUMAB, IPILIMUMAB, PREDNISONE, INFLIXIMAB, |
||||
| 283 | 26926449 |
EU |
73 | 1 |
Cytokine release syndrome, Immune effector cell-associated neurotoxicity syndrome, Acute kidney injury, Metabolic acidosis, Lactic acidosis, Troponin increased, Chest pain, Spinal pain, Pyrexia, Depressed level of consciousness, Disorientation, Mucosal inflammation, |
||||
TECLISTAMAB-CQYV, |
||||
| 284 | 26926508 |
CO |
76 | 1 |
Eructation, Pyrexia, Intestinal haemorrhage, Pneumonia, Bacteraemia, Diarrhoea, Abdominal pain, |
||||
VENETOCLAX, |
||||
| 285 | 26930229 |
55 | 2 | |
Dyspnoea, Pyrexia, |
||||
AMBRISENTAN, TADALAFIL, |
||||
| 286 | 26930301 |
52 | ||
Dry mouth, Pyrexia, Chills, Pain, Muscle tightness, Arthralgia, Vomiting, Diarrhoea, Palpitations, Flushing, Muscular weakness, Depressed mood, Emotional disorder, Brain fog, Aphasia, Peripheral coldness, Decreased appetite, Blood urine present, |
||||
EVOLOCUMAB, |
||||
| 287 | 26914657 |
CN |
76 | 2 |
Full blood count decreased, Pyrexia, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 288 | 26914677 |
CA |
49 | 2 |
Gamma-glutamyltransferase decreased, Influenza like illness, Incontinence, Body temperature decreased, Hypoaesthesia, Abdominal discomfort, Immunodeficiency, Post-traumatic neck syndrome, Abdominal distension, Anxiety, Muscle spasms, Back pain, Pain in jaw, Paraesthesia, Bone pain, Peripheral coldness, Urticaria, Spinal pain, Peripheral swelling, Poor venous access, Pain in extremity, Vasodilatation, Confusional state, Toothache, Chills, Road traffic accident, Retinal detachment, Dizziness, Vein disorder, Feeling cold, Feeling hot, Flushing, Gastritis, Hepatic function abnormal, Impaired healing, Neutrophil count decreased, Oedema peripheral, Metastases to bone, Pyrexia, White blood cell count decreased, Abdominal pain upper, Drug hypersensitivity, Decreased appetite, Dehydration, Blood potassium increased, Fatigue, Chest pain, Asthenia, Blood creatinine increased, Blood cholesterol increased, Platelet count decreased, Mean cell haemoglobin decreased, Arthralgia, Blood pressure decreased, Malaise, Pain, Migraine, Headache, Nausea, Rash, Infusion site haemorrhage, Infusion site bruising, Infusion site erythema, Infusion site induration, Infusion site coldness, Infusion site mass, Infusion site swelling, Drug ineffective, |
||||
EVEROLIMUS, CAPECITABINE, PAMIDRONATE DISODIUM, FULVESTRANT, FENTANYL, MEFENAMIC ACID, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, RANITIDINE, |
||||
| 289 | 26914730 |
CN |
57 | 1 |
Colitis, Haematochezia, Diarrhoea, Blood loss anaemia, Pyrexia, |
||||
ETOPOSIDE, ETOPOSIDE, CARBOPLATIN, CARBOPLATIN, |
||||
| 290 | 26914777 |
CN |
54 | |
Hypersensitivity, Pyrexia, Face oedema, Rash, Pneumonia, |
||||
| 291 | 26914838 |
EU |
53 | 1 |
Dyspnoea at rest, Cough, Pyrexia, Chills, |
||||
NINTEDANIB, |
||||
| 292 | 26914862 |
IN |
61 | 1 |
Weight decreased, Condition aggravated, Diarrhoea, Pyrexia, |
||||
DURVALUMAB, |
||||
| 293 | 26914926 |
CN |
49 | 1 |
Myelosuppression, Diarrhoea, Pyrexia, |
||||
CISPLATIN, CISPLATIN, |
||||
| 294 | 26914946 |
29 | 1 | |
Haemophagocytic lymphohistiocytosis, Cytokine release syndrome, Cytokine release syndrome, Pyrexia, |
||||
ACYCLOVIR, FOLIC ACID, FAMOTIDINE, ALLOPURINOL, URSODIOL, URSOSIOL, LORAZEPAM, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, CEFTRIAXONE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 295 | 26914954 |
CA |
43 | |
Oedema peripheral, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Rheumatic fever, Pneumonia, Retinitis, Red blood cell sedimentation rate increased, Osteoarthritis, Product use issue, Product use in unapproved indication, Prescribed underdose, Prescribed overdose, Off label use, Intentional product use issue, Underdose, Suspected off label use, Suspected off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, OXYCODONE, OXYCODONE, OXYCODONE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 296 | 26914996 |
EU |
79 | |
Dermatitis exfoliative generalised, Oedema peripheral, Oedema genital, Dyspnoea, Pyrexia, Eosinophilia, Blood phosphorus decreased, Hypocalcaemia, |
||||
DENOSUMAB, RELUGOLIX, APALUTAMIDE, |
||||
| 297 | 26915045 |
IN |
68 | 1 |
Pyrexia, Chills, Asthenia, Dry skin, Taste disorder, Nail discolouration, Weight decreased, |
||||
DURVALUMAB, |
||||
| 298 | 26915132 |
CN |
81 | 2 |
Chest discomfort, Pain in extremity, Nausea, Vomiting, Pyrexia, Abdominal pain, |
||||
| 299 | 26915202 |
US |
7 | 2 |
Depressed level of consciousness, Pyrexia, Hyperthermia, Hypothermia, Miosis, Tachycardia, Respiratory depression, Bradycardia, Accidental exposure to product by child, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 300 | 26915221 |
CA |
57 | |
Pain, Adverse event, Pneumonia, Insomnia, Hypertension, Pyrexia, Sinusitis, Palpitations, Joint swelling, Fatigue, Headache, Pruritus, Product distribution issue, Wrong technique in product usage process, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, PREDNISONE, BUPRENORPHINE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
